Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Archivos De Bronconeumologia|March 21, 2022
Radon, Tobacco Exposure and Non-Small Cell Lung Cancer Risk Related to BER and NER Genetic PolymorphismsJosé Ramón Enjo-Barreiro, Alberto Ruano-Ravina, Mónica Pérez-Ríos, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 13, 2026
High leptin levels independent of body mass index are associated with inflammation and poorer treatment response in patients with diffuse large B-cell lymphomaLourdes Hontecillas-Prieto, Daniel J García-Domínguez, Carlos Jiménez-Cortegana, et al.Scientific Reports|December 4, 2020
Polymorphisms in the BER and NER pathways and their influence on survival and toxicity in never-smokers with lung cancerAna Casal-Mouriño, Alberto Ruano-Ravina, María Torres-Durán, et al.Cancer & Metabolism|March 5, 2025
Obesity and overweight in R/R DLBCL patients is associated with a better response to treatment of R2-GDP-GOTEL trial. Potential role of NK CD8 + cells and vitamin DLourdes Hontecillas-Prieto, Daniel J García-Domínguez, Carlos Jiménez-Cortegana, et al.Cancers|March 13, 2024
A Descriptive Study of 103 Primary Cutaneous B-Cell Lymphomas: Clinical and Pathological Characteristics and Treatment from the Spanish Lymphoma Oncology Group (GOTEL)Natividad Martínez-Banaclocha, Francisca Martínez-Madueño, Berta Caballé, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2025
Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung CancerMark M Awad, Patrick M Forde, Nicolas Girard, et al.Cancer Letters|May 27, 2020
Lung cancer survival in never-smokers and exposure to residential radon: Results of the LCRINS studyAna Casal-Mouriño, Alberto Ruano-Ravina, María Torres-Durán, et al.Environmental Research|November 8, 2019
Lung cancer risk and do-it-yourself activities. A neglected risk factor for lung cancerMaría Lorenzo-González, Alberto Ruano-Ravina, María Torres-Durán, et al.Frontiers in Oncology|August 12, 2021
Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET StudyEloisa Jantus-Lewintre, Bartomeu Massutí Sureda, José Luis González Larriba, et al.Nature Medicine|May 31, 2025
Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase 2 NeoCOAST-2 trialTina Cascone, Laura Bonanno, Florian Guisier, et al.Pageof 5